S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
The Strategic Gold Play You Haven't Heard About (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
The Strategic Gold Play You Haven't Heard About (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
The Strategic Gold Play You Haven't Heard About (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
The Strategic Gold Play You Haven't Heard About (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
The Strategic Gold Play You Haven't Heard About (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
The Strategic Gold Play You Haven't Heard About (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
The Strategic Gold Play You Haven't Heard About (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
The Strategic Gold Play You Haven't Heard About (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
The Strategic Gold Play You Haven't Heard About (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
The Strategic Gold Play You Haven't Heard About (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
The Strategic Gold Play You Haven't Heard About (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
The Strategic Gold Play You Haven't Heard About (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund

Semler Scientific Stock Price, News & Analysis (NASDAQ:SMLR)

$41.91
+1.18 (+2.90%)
(As of 12/5/2023 ET)
Compare
Today's Range
$40.60
$42.73
50-Day Range
$25.37
$41.91
52-Week Range
$19.12
$43.38
Volume
100,983 shs
Average Volume
56,860 shs
Market Capitalization
$288.05 million
P/E Ratio
16.76
Dividend Yield
N/A
Price Target
N/A

SMLR stock logo

About Semler Scientific Stock (NASDAQ:SMLR)

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups, long-term care, or remote patient monitoring organizations. It offers its products through salespersons and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

SMLR Stock Price History

SMLR Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Semler Scientific: Q3 Earnings Insights
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Semler Scientific director buys 77,771 shares
See More Headlines
Receive SMLR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Semler Scientific and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
12/06/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/19/2024

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SMLR
Fax
N/A
Employees
127
Year Founded
N/A

Profitability

Net Income
$14.32 million
Pretax Margin
37.72%

Debt

Sales & Book Value

Annual Sales
$66.92 million
Cash Flow
$2.27 per share
Book Value
$8.14 per share

Miscellaneous

Free Float
4,811,000
Market Cap
$288.05 million
Optionable
Not Optionable
Beta
0.78
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Dr. Douglas Murphy-Chutorian M.D. (Age 69)
    Interim CEO, President & Director
    Comp: $870.46k
  • Dr. Herbert J. Semler (Age 95)
    Founder & Chairman Emeritus
    Comp: $41.25k
  • Ms. Renae Cormier (Age 51)
    CFO, Principal Accounting Officer, Head of Corp. Communications & Bus. Strategy and Secretary
  • Ms. Jennifer Oliva Herrington
    Chief Operating Officer
  • Mr. Shane Reid
    Chief Technology Officer
  • Ms. Cindy Guinasso
    Senior Vice President of Business Development














SMLR Stock Analysis - Frequently Asked Questions

How have SMLR shares performed in 2023?

Semler Scientific's stock was trading at $33.00 at the beginning of 2023. Since then, SMLR stock has increased by 27.0% and is now trading at $41.91.
View the best growth stocks for 2023 here
.

When is Semler Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 19th 2024.
View our SMLR earnings forecast
.

How were Semler Scientific's earnings last quarter?

Semler Scientific, Inc. (NASDAQ:SMLR) announced its earnings results on Thursday, November, 9th. The company reported $0.71 earnings per share for the quarter. The firm earned $16.32 million during the quarter. Semler Scientific had a trailing twelve-month return on equity of 30.96% and a net margin of 29.25%.

Who are Semler Scientific's major shareholders?

Semler Scientific's stock is owned by a variety of institutional and retail investors. Top institutional investors include LSV Asset Management (2.10%), Acadian Asset Management LLC (1.17%), Walleye Capital LLC (1.15%), Jacobs Levy Equity Management Inc. (1.01%), Northern Trust Corp (0.79%) and Charles Schwab Investment Management Inc. (0.57%). Insiders that own company stock include Douglas Murphy-Chutorian, Eric Semler, HC Chang & Diana Sho William and Wayne T Pan.
View institutional ownership trends
.

How do I buy shares of Semler Scientific?

Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SMLR) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -